ArticlePLOS global public health2025
Targeted vaccination is effective for mpox clade Ib in England despite increased household transmission: Predictions from a modelling study.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection.Tropical medicine and infectious disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mpox is an emerging infectious disease with increasing global relevance. In 2024, a new clade, mpox clade Ib, was associated with high household attack rates and case fatality, raising concerns about sustained human-to-human transmission outside endemic areas. We developed and applied an individual-based probabilistic framework for mpox incorporating sexual and household contact patterns using data from the National Survey of Sexual Attitudes and Lifestyles 3 (NATSAL3). Individual and population-level reproduction numbers were estimated using setting-specific secondary attack rates. Vaccination impact was assessed across scenarios varying household attack rates, vaccine effectiveness, and distribution strategies. We predict that fewer than 3 out of 100 individuals generated more than one secondary case of clade Ib in England, with a population reproduction number of 0.69 (95%CI 0.66 - 0.71). Individuals reporting both same-sex and opposite sexual contact disproportionately contributed to transmission potential. Increasing household secondary attack rates led to modest increases in the population reproduction number due to individuals with the highest reproduction numbers having lower than average numbers of household contacts. Targeted vaccination, focused on individuals with higher numbers of sexual contacts, consistently outperformed non-targeted strategies, requiring lower vaccine coverage to achieve control even under elevated household transmission. Vaccine effectiveness against infection and onward transmission critically influenced the success of vaccination programs. Despite higher household transmission risks, targeted vaccination remains an effective strategy for controlling mpox clade Ib in England. Transmission dynamics are strongly shaped by underlying contact structures, emphasizing the importance of network-informed interventions. Rapid, network-informed models can provide valuable early guidance for emerging infectious diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.